SCHEMBL20340489

SCHEMBL20340489

Cc1cc([C@H]2CCC(=NO)c3ccccc32)ccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.40
SLC6A4 P31645 7/20 0.40
SLC6A3 Q01959 7/20 0.40
CYP3A4 P08684 5/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 3/20 0.40
NPC1 O15118 2/20 0.40
CYP2D6 P10635 2/20 0.40
MTOR P42345 2/20 0.40
RAB9A P51151 2/20 0.40
MLNR O43193 1/20 0.40
NR1I2 O75469 1/20 0.40
ABCB11 O95342 1/20 0.40
ESR1 P03372 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
ABCB1 P08183 1/20 0.40
ADRB1 P08588 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20436755 1.00 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL10041953 1.00 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL15491044 1.00 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL10071230 0.90 MEN1 (0.40) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL8276213 0.89 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL20436754 0.88 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL8920488 0.88 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL10041960 0.88 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL20341081 0.88 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CYP3A4MEN1
SCHEMBL10041954 0.88 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10011559-B2 Preparation of chiral amides and amines SUNOVION PHARMACEUTICALS INC. (US) 2018-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10011559-B2 Preparation of chiral amides and amines PNMT, ALKBH5, ALKBH2 SLC6A2 374/4885SLC6A4 827/4885SLC6A3 1382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.